Finding Patterns In Clinical Trial Experiences of Patients With Eczema

Power Life Sciences Inc.500 enrolled

Overview

Historically, participation in clinical trials has been skewed towards certain groups. However, research on the factors that influence participation, both positive and negative, is limited. Eczema clinical trial patients help us identify these factors by sharing trial experiences during the course of the observational medical study. This study will include a diverse group of participants to gather a wide range of information on clinical trial experiences. The collected data will then be used to benefit future eczema patients who are considering participating in a clinical study.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Eczema

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has been diagnosed with eczema * Patient is 18 years old * Patient has self-identified as planning to enroll in an observational clinical study Exclusion Criteria: * Patient does not understand, sign, and return consent form * Patient is pregnant * Inability to perform regular electronic reporting

Outcomes

Primary Outcomes

Number of patients who decide to enroll in a clinical trial for eczema.

Time frame: 3 months

Rate of patients who remain in an eczema clinical trial to completion.

Time frame: 12 months

Central Contacts

Michael B Gill

CONTACT

4159004227 bask@withpower.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.